How much is Pangea Bio worth in 2026?

Pangea Bio has a current valuation of $78.7M based on their Early Stage VC round and secondary market data.

How much funding has Pangea Bio raised?

Pangea Bio has raised $20.5M in total funding across 1 funding rounds.

Pangea Bio

Drug DiscoveryWebsite

Pangea Bio valuation and funding history | Last updated: October 28, 2024 | 1 funding rounds

Current Valuation

$78.7M

As of October 28, 2024

Total Funding Raised

$20.5M

Across 1 round

Last Round

Early Stage VC

$2.9M

Last Funding

Oct 2024

Funding date

Capital Efficiency

3.83x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 6, 2023	Early Stage VC (Series A)	$15.6M	N/A	-

Valuation Analysis

Current Valuation Metrics

Pangea Bio is currently valued at $78.7M as of October 28, 2024. The company has raised a total of $20.5M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 3.83x, Pangea Bio has achieved a valuation that is 3.83 times the total capital raised.

Track Pangea Bio Valuation Updates

Get notified when Pangea Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Pangea Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Pangea Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Pangea Bio Worth in 2026?

Pangea Bio is a leading private company in the Drug Discovery sector. Track Pangea Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Pangea Bio Valuation is Determined

Private company valuations like Pangea Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.